Biomarkers for clinical use in psychiatry: where are we and will we ever get there?
作者信息
Yatham Lakshmi N
机构信息
Department of Psychiatry, Institute of Mental Health, University of British Columbia, Vancouver, BC, Canada.
出版信息
World Psychiatry. 2023 Jun;22(2):263-264. doi: 10.1002/wps.21079.
Abstract
摘要
相似文献
1
Biomarkers for clinical use in psychiatry: where are we and will we ever get there?用于精神病学临床的生物标志物：我们目前的进展如何，以及我们能否实现目标？
World Psychiatry. 2023 Jun;22(2):263-264. doi: 10.1002/wps.21079.
2
The Task before Psychiatry Today Redux: STSPIR*.当今精神病学面临的任务再探讨：STSPIR*
Mens Sana Monogr. 2014 Jan;12(1):35-70. doi: 10.4103/0973-1229.130295.
3
Psychiatrist in Court: Indian Scenario.法庭上的精神科医生：印度情况
Indian J Psychol Med. 2019 Mar-Apr;41(2):126-132. doi: 10.4103/IJPSYM.IJPSYM_53_19.
4
Stratified psychiatry: Tomorrow's precision psychiatry?分层精神病学：明日的精准精神病学？
Eur Neuropsychopharmacol. 2022 Feb;55:14-19. doi: 10.1016/j.euroneuro.2021.10.863. Epub 2021 Nov 9.
5
Biomarkers in psychiatry: a clinician's viewpoint.精神病学中的生物标志物：临床医生的观点。
Br Med Bull. 2020 Oct 14;135(1):23-27. doi: 10.1093/bmb/ldaa019.
6
Disease modification in OA - will we ever get there?骨关节炎的病情改善——我们能实现吗？
Nat Rev Rheumatol. 2019 Mar;15(3):133-135. doi: 10.1038/s41584-019-0174-1.
7
Prediction of treatment outcomes in psychiatry--where do we stand ?精神病学治疗结果的预测——我们目前的状况如何？
Dialogues Clin Neurosci. 2014 Dec;16(4):455-64. doi: 10.31887/DCNS.2014.16.4/fmcmahon.
8
Machine learning as the new approach in understanding biomarkers of suicidal behavior.机器学习作为理解自杀行为生物标志物的新方法。
Bosn J Basic Med Sci. 2021 Aug 1;21(4):398-408. doi: 10.17305/bjbms.2020.5146.
9
Editorial: The times they are a-changin': paradigm shifts in child and adolescent psychology and psychiatry.社论：时代在变：儿童和青少年心理学与精神病学的范式转变。
J Child Psychol Psychiatry. 2022 Apr;63(4):357-359. doi: 10.1111/jcpp.13604.
10
Graded Exposure Therapy for Fear Avoidance Behaviour After Concussion (GET FAB): protocol for a multisite Canadian randomised controlled trial.分级暴露疗法治疗脑震荡后回避行为恐惧（GET FAB）：一项多中心加拿大随机对照试验方案。
BMJ Open. 2024 Jul 1;14(6):e086602. doi: 10.1136/bmjopen-2024-086602.
引用本文的文献
1
Racial bias in AI-mediated psychiatric diagnosis and treatment: a qualitative comparison of four large language models.人工智能介导的精神科诊断与治疗中的种族偏见：四个大语言模型的定性比较
NPJ Digit Med. 2025 Jun 4;8(1):332. doi: 10.1038/s41746-025-01746-4.
2
Characteristics of Trials Preceding FDA Approval of Novel Psychiatric Drugs.美国食品药品监督管理局（FDA）批准新型精神药物之前的试验特征。
JAMA Netw Open. 2025 Jan 2;8(1):e2456588. doi: 10.1001/jamanetworkopen.2024.56588.
3
What is the relationship between exposure to environmental pollutants and severe mental disorders? A systematic review on shared biological pathways.接触环境污染物与严重精神障碍之间的关系是什么？关于共享生物学途径的系统综述。
Brain Behav Immun Health. 2024 Dec 12;43:100922. doi: 10.1016/j.bbih.2024.100922. eCollection 2025 Feb.
4
Judged by your neighbors: Brain structural normativity profiles for large and heterogeneous samples.由邻居评判：大型异质样本的脑结构规范性概况
medRxiv. 2025 Feb 19:2024.12.24.24319598. doi: 10.1101/2024.12.24.24319598.
5
Is There a Relationship between Psychotic Disorders and the Radicalization Process? A Systematic Review.精神障碍与激进化过程之间是否存在关系？系统综述。
Medicina (Kaunas). 2024 Jun 1;60(6):926. doi: 10.3390/medicina60060926.
6
Facts and myths about use of esketamine for treatment-resistant depression: a narrative clinical review.关于艾氯胺酮用于难治性抑郁症治疗的事实与误解：一项叙述性临床综述
Front Psychiatry. 2024 May 15;15:1394787. doi: 10.3389/fpsyt.2024.1394787. eCollection 2024.
7
Advances in the understanding of the pathophysiology of schizophrenia and bipolar disorder through induced pluripotent stem cell models.通过诱导多能干细胞模型深入了解精神分裂症和双相情感障碍的病理生理学。
J Psychiatry Neurosci. 2024 Mar 15;49(2):E109-E125. doi: 10.1503/jpn.230112. Print 2024 Jan-Feb.
8
Leveraging big data for causal understanding in mental health: a research framework.利用大数据促进对心理健康的因果理解：一个研究框架。
Front Psychiatry. 2024 Feb 19;15:1337740. doi: 10.3389/fpsyt.2024.1337740. eCollection 2024.
9
Towards the First Biomarker Test for Bipolar Spectrum Disorder: An Evaluation of 199 Patients in an Outpatient Setting.迈向双相谱系障碍的首个生物标志物检测：门诊环境中199例患者的评估
J Pers Med. 2023 Jul 7;13(7):1108. doi: 10.3390/jpm13071108.
本文引用的文献
1
Candidate biomarkers in psychiatric disorders: state of the field.精神疾病中的候选生物标志物：该领域的现状。
World Psychiatry. 2023 Jun;22(2):236-262. doi: 10.1002/wps.21078.
2
Human-Induced Pluripotent Stem Cell Technology: Toward the Future of Personalized Psychiatry.人类诱导多能干细胞技术：迈向个性化精神病学的未来。
J Pers Med. 2022 Aug 20;12(8):1340. doi: 10.3390/jpm12081340.
3
Strategies and foundations for scientific discovery in longitudinal studies of bipolar disorder.双相障碍纵向研究中的科学发现策略和基础。
Bipolar Disord. 2022 Aug;24(5):499-508. doi: 10.1111/bdi.13198. Epub 2022 Mar 18.
4
Human iPSC-Based Modeling of Central Nerve System Disorders for Drug Discovery.基于人诱导多能干细胞的中枢神经系统疾病模型用于药物发现。
Int J Mol Sci. 2021 Jan 26;22(3):1203. doi: 10.3390/ijms22031203.
5
DSM-5 field trials in the United States and Canada, Part II: test-retest reliability of selected categorical diagnoses.《精神障碍诊断与统计手册》第五版（DSM-5）在美国和加拿大的现场测试，第二部分：部分类别诊断的重测信度。
Am J Psychiatry. 2013 Jan;170(1):59-70. doi: 10.1176/appi.ajp.2012.12070999.
6
The Alzheimer's disease neuroimaging initiative.阿尔茨海默病神经影像学计划。
Neuroimaging Clin N Am. 2005 Nov;15(4):869-77, xi-xii. doi: 10.1016/j.nic.2005.09.008.
Zotero 插件